

| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash Dividend Payment Amount and Rates | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount and Rate of Cash Dividend Stock Dividend Payment | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional Explanations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Our Company incurred a net loss for the 2025 fiscal year of TL 246,202,529 according to its consolidated financial statements, which were prepared in accordance with the Capital Markets Board's Communiqué No. II-14.1 on the Principles of Financial Reporting in the Capital Markets, in compliance with Turkish Accounting Standards/Turkish Financial Reporting Standards ("TAS/TFRS") and the formats determined by the CMB, and independently audited by Eren Bağımsız Denetim A.Ş. (A member firm of Grant Thornton International). According to the financial statements prepared within the framework of the relevant provisions of the Turkish Commercial Code No. 6102 and the Tax Procedure Law No. 213, the Company incurred a net loss of TL 205,422,041.30.
It has been resolved that the loss for the 2025 fiscal year be added to prior years' losses to be offset against profits that may arise in future periods and, accordingly, that shareholders be informed that no dividend distribution will be made, and that this matter be submitted for approval to the General Assembly. The resolution was approved at the Ordinary General Assembly Meeting for the 2025 fiscal year held on August 13, 2026. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DIVIDEND DISTRIBUTION TABLE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PENGUEN GIDA SANAYİ A.Ş. 01.01.2025/31.12.2025 Period Dividend Payment Table (TL) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividend Payment Rates Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividend Rate Table Explanations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pursuant to the Communiqué on Principles of Financial Reporting in Capital Markets (II-14.1) of the Capital Markets Board, the Company's consolidated financial statements for the 2025 fiscal year, prepared in accordance with the Turkish Accounting Standards/Turkish Financial Reporting Standards ("TAS/TFRS") and the formats prescribed by the Capital Markets Board, and independently audited by Eren Bağımsız Denetim A.Ş. (a member firm of Grant Thornton International), reported a net loss for the period of TRY 246,202,529. According to the statutory financial statements prepared in accordance with the relevant provisions of the Turkish Commercial Code No. 6102 and the Tax Procedure Law No. 213, the Company recorded a net loss for the period of TRY 205,422,041.30.
The Board of Directors has resolved to carry forward the loss incurred for the 2025 fiscal year by offsetting it against future profits through its addition to accumulated losses, to make no dividend distribution for the 2025 fiscal year, to inform the shareholders accordingly, and to submit this proposal to the approval of the General Assembly. |
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.